Soterix Medical Announces Expanded Clinical Trials for Alzheimer's disease and Mild Cognitive Impairment
Press release content from PR Newswire. The AP news staff was not involved in its creation. Soterix Medical Announces Expanded Clinical Trials for Alzheimer’s disease and Mild Cognitive Impairment December 24, 2020 GMT (PRNewsfoto/Soterix Medical) NEW YORK, Dec. 24, 2020 /PRNewswire/ -- Soterix Medical Inc. , the global leader in non-invasive stimulation and synergistic brain imaging technologies, is pleased to report expanded clinical trials of its proprietary neuromodulation technologies for Alzheimer’s disease and Mild Cognitive Impairment. Adults over age 65 represent the fastest grow...
Source: apnews.com